Pharmacopsychiatry

Papers
(The TQCC of Pharmacopsychiatry is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
27
SARS-CoV-2-Infection in People Addicted to Illegal Drugs – Is There a Protective Effect of Opioid Maintenance Treatment?25
The Role of Circadian Rhythmicity and CLOCK Genes in Psychiatry23
Time-Dependent Effects of Metformin and Olanzapine on the Metabolic System18
Effects of a citalopram treatment on the amyloid-β-pathology and behaviour in the 5xFAD Alzheimer mouse model17
2001–2021 Comparative Persistence of Oral Antipsychotics in Patients Initiating Treatment: Superiority of Clozapine in Time-to-Treatment Discontinuation17
Escitalopram and Clonazepam Affect Gasotransmitter-related Enzyme (nNOS, HO-2, CBS) Gene Expression in the Rat Brain16
The Effect of Kidney Function and Cardiovascular and Anti-Inflammatory Comedications on the Serum Concentration of Risperidone under Naturalistic Conditions14
Challenges Related to the Implementation of Measurement-Based Care for the Treatment of Major Depressive Disorder: A Feasibility Study13
Twenty-Three Years of Declining Lithium Use: Analysis of a Pharmacoepidemiological Dataset from German-Speaking Countries12
Utility of Antidepressant Randomized Controlled Trials for Regular Treatment11
The Mini-TRH Test11
Exposure to Psychotropic Drugs and Colorectal Cancer Risk in Patients with Affective Disorder: A Nested Case-Control Study11
The Role of Mood Stabilizers in Children and Adolescents with Anorexia Nervosa: A 1-year Follow-Up, Propensity Score-Matched Study10
The Endocannabinoid System in PTSD: Molecular Targets for Modulating Fear and Anxiety9
Neutral sphingomyelinase is a major driver of sex-differences in depression and alcohol-abuse9
Psychiatric syndromes associated with anti-neural autoantibodies differ in their affective psychopathology from those that are not9
8
Effects of Pharmacokinetic Gene Variation on Therapeutic Drug Levels and Antidepressant Treatment Response7
News on the Role of Antidepressants in and for COVID-19 and Long COVID7
Recreational Cannabis Legalization: No Contribution to Rising Prescription Stimulants in the USA7
Mineralocorticoid and glutamatergic NMDA receptor stimulation does not influence spatial learning and memory in depressed individuals and healthy control7
GABAergic Effects of Etifoxine and Alprazolam Assessed by Double Pulse TMS7
Can Red Blood Cell Membrane Fatty Acids Predict Intracellular Lithium Concentration in Bipolar Disorder? A Cross-Sectional Study7
7
Social Robots in Psychiatry for Patients Suffering from Major Depression—A Pilot Study6
POMC and NR3C1-1F DNA methylation in major depressive disorder and electroconvulsive therapy6
Patient and Physician Exposure to Artificial Intelligence Hype6
6
Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot Survey5
Vitamin D: Adjustment of Per1 expression in study participants with an ADHD diagnosis5
Ausschreibung Peter Müller Preis für Forschung im Bereich Schizophrenie5
Intestinal Flora and Depression: Interaction Mechanisms and Therapeutic Prospects5
4
Artificial Intelligence in Drug Discovery and Development: Raising Quality per Decision4
Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes4
Bariatric surgery: impact on oral aripiprazole and fluoxetine bioavailability – A clinical case4
Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannab4
Effects of Anesthesia Changes During Maintenance ECT: A Longitudinal Comparison of Seizure Quality Under Anesthesia Using Propofol/Esketamine Versus Methohexita3
Does Lidocaine Shorten Seizure Duration in Electroconvulsive Therapy?3
Overview: Chronic Pain and Cannabis-Based Medicines3
Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease3
3
A retrospective comparison of etomidate and methohexital as anesthetic agents for maintenance electroconvulsive therapy3
Cardiovascular Effects of Non-Selective Monoamine Oxidase Inhibitors and Intranasal Esketamine Combination in Depression – A Quasi-Experimental Design with Baye3
Linkage of Young Mania Rating Scale to Clinical Global Impression Scale to Enhance Utility in Clinical Practice and Research Trials3
Increased Odds of Cognitive Impairment in Adults with Depressive Symptoms and Antidepressant Use3
Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis3
2
Functional connectivity analysis of locus coeruleus in patients with major depressive episode2
2
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs2
Major depressive episodes with high rapid eye movement density do not respond better to rapid eye movement sleep suppressive antidepressants than to others2
Revisiting the World’s Strictest COVID-19 Lockdown: Formidable Mental Health Challenges2
Ausschreibung Peter Müller Preis für Forschung im Bereich Schizophrenie2
QTc interval alterations during antidepressant treatment with escitalopram and venlafaxine2
The Relevance of Integrating CYP2C19 Phenoconversion Effects into Clinical Pharmacogenetics2
Monitoring Anesthetic Depth Using the Patient State Index in Electroconvulsive Therapy Improves Seizure Quality2
Utilizing Machine Learning to Forecast 3-Month Remission Outcomes in Bipolar Disorder Patients Treated with Lithium2
Heart Rate-Corrected QT Interval Dynamics Following Antidepressant Switching from Escitalopram to High-Dose Venlafaxine: Cardiac Safety Insights from the Early 2
Glycine and the ketamine model of schizophrenia: Modulating the N-methyl-D-aspartate receptor (NMDAR) offers new insights into the glutamate hypothesis of schiz2
Blocking the Reflection: Milestones and Hurdles for Digital Twins in Mental Health2
Impact of Antipsychotic Medications on Weight Gain and Eating Disorder-Related Psychopathology in Adult Inpatients with Anorexia Nervosa2
Metformin is Protective Against the Development of Mood Disorders2
0.57906317710876